Crohn's disease: on the occasion of the 80th anniversary of description
- Authors: Parfenov AI1
-
Affiliations:
- Центральный научно-исследовательский институт гастроэнтерологии, Москва
- Issue: Vol 85, No 8 (2013)
- Pages: 35-42
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31303
- ID: 31303
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A I Parfenov
Центральный научно-исследовательский институт гастроэнтерологии, Москва
Email: asfold@mail.ru
References
- Crohn's Disease and Ulcerative Colitis - From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach. Baumgart DC, ed. New York: Springer 2012.
- Lee A., Griffiths .A., Parab R.S. et al. Association of Mycobacterium avium subspecies paratuberculosis with Crohn Disease in pediatric patients. J Pediatr Gastroenterol Nutr 2011; 52: 170-174.
- Nakase H., Tamaki H., Matsuura M. et al. Involvement of mycobacterium avium subspecies paratuberculosis in TNF-α production from macrophage: Possible link between MAP and immune response in Crohn's disease. Inflammatory bowel diseases. 2011; 17 (11): E140-E142.
- Barreau F., Madre C., Meinzer U. et al. Nod2 regulates the host response towards microfl ora by modulating T cell function and epithelial permeability in mouse Peyer's patches. Gut 2010; 59: 207-217.
- Baumgart D., Sandborn W. Crohn's Disease. The Lancet 2012; 380 (9853): 1590-1605.
- Colombel J.F., Sandborn W.J., Reinisch W. et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010; 362: 1383-1395.
- Cosnes J., Cattan S., Blain A. et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-250.
- Al-Hawary M., Zimmermann E.M. A New Look at Crohn's Disease. Novel Imaging Techniques. Curr Opin Gastroenterol 2012; 28 (4): 334-340.
- Ferrante M., Henckaerts L., Joossens M. et al. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 2007; 56 (10): 1394-1403.
- Seow C.H., Stempak J.M., Xu W. et al. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Am J Gastroenterol 2009; 104 (6): 1426-1434.
- Perencevich M., Burakoff R. Use of antibiotics in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2006; 12 (7): 651-664.
- Khan K., Ullman T., Ford A. et al. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol 2011; 106 (4): 661-673.
- Dignass A., Van Assche G., Lindsay J.O. et al. The second European evidence-based consensus on the diagnosis and management of Crohn's Disease: current management. J. Crohn's Colitis.2010; 4: 28-62.
- Gordon M., Naidoo K., Thomas A.G., Akobeng A.K. Oral 5-aminosalicylic acid for maintenance of surgically-induced remission in Crohn's disease. Cochrane Database Syst Rev 2011; 1: CD008414.
- Seow C.H., Benchimol E.I., Griffiths A.M. et al. Budesonide for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2008; CD000296.
- Dignass A., Van Assche G., Lindsay J.O. et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: current management. J. Crohns Colitis 2010; 4: 28-62.
- Peyrin-Biroulet L., Deltenre P., Ardizzone S. et al. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis. Am J Gastroenterol 2009; 104: 2089-2096.
- Lin M.V., Blonski W., Lichtenstein G.R., Present D.H. What is the optimal therapy for Crohn's disease: step-up or top-down? Expert Rev Gastroenterol Hepatol 2010; 4: 167-180.
- Князев О.В., Парфенов А.И., Ручкина И.Н. и др. Новые возможности преодоления вторичной неэффективности антицитокиновой терапии у больных воспалительными заболеваниями кишечника. Тер арх 2013; 2: 57-60.
- Neurath M.F., Travis S.P.L. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut 2012; 61 (11): 1619-1635.
Supplementary files
